Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
The nature of genetic susceptibility to multiple sclerosis: constraining the possibilities.
Antibody producing B lineage cells invade the central nervous system predominantly at the time of and triggered by acute Epstein-Barr virus infection: A hypothesis on the origin of intrathecal immunoglobulin synthesis in multiple sclerosis.
The effects of diet on the severity of central nervous system disease: One part of lab-to-lab variability.
Divergent Trends of Anti-JCPyV Serum Reactivity and Neutralizing Activity in Multiple Sclerosis (MS) Patients during Treatment with Natalizumab.
Activity of secukinumab, an anti-IL-17A antibody, on brain lesions in RRMS: results from a randomized, proof-of-concept study.
Receptos to deliver scientific presentation at Digestive Disease Week 2012 about the therapeutic role of RPC1063 in inflammatory bowel disease
Glial cells as drug targets: What does it take?
Protein microarrays guide tolerizing DNA vaccine treatment of autoimmune encephalomyelitis.
Multiple sclerosis: Mitoxantrone promotes differential effects on immunocompetent cells in vitro.
Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica.
Widespread cortical thinning in patients with neuromyelitis optica spectrum disorder.
Magnetization transfer ratio in the delayed-release dimethyl fumarate DEFINE study.
Two cases of relapses in primary progressive multiple sclerosis after fingolimod withdrawal.
Demyelination induces transport of ribosome-containing vesicles from glia to axons: evidence from animal models and MS patient brains.
Synergistic Effects of Reserve and Adaptive Personality in Multiple Sclerosis.
Extavia Prescribing Information
NF-κB transcriptional activation by TNFα requires phospholipase C, extracellular signal-regulated kinase 2 and poly(ADP-ribose) polymerase-1.
Prevalence of people who could benefit from augmentative and alternative communication (AAC) in the UK: determining the need.
Postpartum relapses increase the risk of disability progression in multiple sclerosis: the role of disease modifying drugs.
Chronic Inflammatory Demyelinating Polyneuropathy Following Anti-TNF-α Therapy With Infliximab for Crohn's Disease.
Sphingosine-1-Phosphate (S1P) Impacts Presynaptic Functions by Regulating Synapsin I Localization in the Presynaptic Compartment.
8th International Congress on Autoimmunity
Common and Rare Manifestations of Neuromyelitis Optica Spectrum Disorder.
Epigenetic modifications of Dexras 1 along the nNOS pathway in an animal model of multiple sclerosis.
Knockdown of Lingo1b protein promotes myelination and oligodendrocyte differentiation in zebrafish.
Pages
« first
‹ previous
…
84
85
86
87
88
89
90
91
92
…
next ›
last »